InvestSMART

CSL Limited (ASX: CSL) - Announcements

Current share price for CSL : $202.920 1.62 (0.79%)+

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$97,378 Appendix 3B 2 Apr 2019 3:23PM $200.235 $202.920 risen by 1.34%
$97,378 Appendix 3B 12 Mar 2019 4:52PM $198.610 $202.920 risen by 2.17%
$97,378 Change of Director's Interest Notice 21 Feb 2019 4:42PM $185.500 $202.920 risen by 9.39%
$97,378 Update - Dividend/Distribution - CSL 20 Feb 2019 9:40AM $184.000 $202.920 risen by 10.28%
$97,378 Appendix 3B 19 Feb 2019 9:32AM $187.040 $202.920 risen by 8.49%
$97,378 Dividend/Distribution - CSL 13 Feb 2019 8:53AM $193.690 $202.920 risen by 4.77%
$97,378 Half Year Results Analyst Presentation 13 Feb 2019 8:53AM $193.690 $202.920 risen by 4.77%
$97,378 Appendix 4D and Half Year Accounts 13 Feb 2019 8:53AM $193.690 $202.920 risen by 4.77%
$97,378 Notice of Investor/Analyst Briefing - Half Year Results 2019 6 Feb 2019 8:20AM $193.030 $202.920 risen by 5.12%
$97,378 Appendix 3B 29 Jan 2019 1:22PM $195.240 $202.920 risen by 3.93%
$97,378 2019 JP Morgan Healthcare Conference 10 Jan 2019 8:25AM $195.100 $202.920 risen by 4.01%
$97,378 CSL R&D Investor Briefing 5 Dec 2018 8:25AM $181.780 $202.920 risen by 11.63%
$97,378 Notice of Research & Development Investor Briefing 30 Nov 2018 9:07AM $180.800 $202.920 risen by 12.23%
$97,378 Becoming a substantial holder 5 Nov 2018 8:23AM $187.520 $202.920 risen by 8.21%
$97,378 Change of Director's Interest Notice 1 Nov 2018 10:15AM $188.550 $202.920 risen by 7.62%
$97,378 Final Director's Interest Notice 22 Oct 2018 3:22PM $185.290 $202.920 risen by 9.51%
$97,378 Final Director's Interest Notice 22 Oct 2018 3:21PM $185.290 $202.920 risen by 9.51%
$97,378 Initial Director's Interest Notice 22 Oct 2018 3:18PM $185.360 $202.920 risen by 9.47%
$97,378 Change of Director's Interest Notice 19 Oct 2018 12:01PM $186.265 $202.920 risen by 8.94%
$97,378 Results of Meeting 17 Oct 2018 4:30PM $193.000 $202.920 risen by 5.14%
$97,378 CSL Chairmans Address and CEOs Presentation 17 Oct 2018 12:56PM $191.500 $202.920 risen by 5.96%
$97,378 Appendix 3B 25 Sep 2018 11:02AM $204.660 $202.920 fallen by 0.85%
$97,378 Change of Director's Interest Notice 21 Sep 2018 3:05PM $206.865 $202.920 fallen by 1.91%
$97,378 Appendix 4G - Key to Disclosures 14 Sep 2018 8:25AM $206.340 $202.920 fallen by 1.66%
$97,378 CSL Annual Report to shareholders 14 Sep 2018 8:25AM $206.340 $202.920 fallen by 1.66%

651 - 675 of 1207 results

Page 27 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.